Prawo i regulacje · 14/01/2022

DEA Proposes Scheduling of Five Tryptamine Hallucinogens

The Drug Enforcement Administration has proposed placing 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I of the Controlled Substances Act, subject to regulatory controls and sanctions.